Prediction of regression of retinal neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy

Retinal Neovascularisation

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Case Medical Research ◽

10.31525/ct1-nct04278417 ◽

2020 ◽

Author(s):

Keyword(s):

Diabetic Retinopathy ◽

Efficacy And Safety ◽

Photocoagulation Laser

Faculty Opinions recommendation of Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13696956.15111056 ◽

2012 ◽

Author(s):

George Williams ◽

Emmanuel Chang

Keyword(s):

Diabetic Retinopathy ◽

Argon Laser ◽

Pattern Scan Laser

Faculty Opinions recommendation of Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727273826.793539313 ◽

2017 ◽

Author(s):

Quan Dong Nguyen

Keyword(s):

Diabetic Retinopathy ◽

Factors Associated

Intravitreal anti‐vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta‐analysis

Acta Ophthalmologica ◽

10.1111/aos.14681 ◽

2020 ◽

Author(s):

Matteo Fallico ◽

Andrea Maugeri ◽

Andrew Lotery ◽

Antonio Longo ◽

Vincenza Bonfiglio ◽

...

Keyword(s):

Systematic Review ◽

Diabetic Retinopathy ◽

Growth Factors ◽

Meta Analysis ◽

Combined Treatment ◽

Vascular Endothelial Growth Factors ◽

Vascular Endothelial ◽

Endothelial Growth Factors

Long-term review of driving potential following bilateral panretinal photocoagulation for proliferative diabetic retinopathy

Diabetic Medicine ◽

10.1111/j.1464-5491.2008.02623.x ◽

2009 ◽

Vol 26 (1) ◽

pp. 97-99 ◽

Cited By ~ 7

Author(s):

S. A. Vernon ◽

J. Bhagey ◽

M. Boraik ◽

H. El-Defrawy

Keyword(s):

Diabetic Retinopathy ◽

Driving Potential

Structural and Functional Assessment of Macula in Patients with High-Risk Proliferative Diabetic Retinopathy Submitted to Panretinal Photocoagulation and Associated Intravitreal Bevacizumab Injections: A Comparative, Randomised, Controlled Trial

Ophthalmologica ◽

10.1159/000348605 ◽

2013 ◽

Vol 230 (1) ◽

pp. 1-8 ◽

Cited By ~ 8

Author(s):

Rony Carlos Preti ◽

Lisa Mariel Vasquez Ramirez ◽

Mário Luiz Ribeiro Monteiro ◽

David E. Pelayes ◽

Walter Yukihiko Takahashi

Keyword(s):

Diabetic Retinopathy ◽

High Risk ◽

Randomised Controlled Trial ◽

Functional Assessment ◽

Controlled Trial ◽

Intravitreal Bevacizumab ◽

Randomised Controlled

Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation

Eye ◽

10.1038/s41433-020-01384-y ◽

2021 ◽

Author(s):

Young Joo Park ◽

Jeeyun Ahn ◽

Tae Wan Kim ◽

Sang Jun Park ◽

Kwangsic Joo ◽

...

Keyword(s):

Diabetic Retinopathy ◽

Vitreous Haemorrhage ◽

Panretinal Photocoagulation

Cost Analysis of Intravitreal Aflibercept vs Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy

JAMA Ophthalmology ◽

10.1001/jamaophthalmol.2021.1565 ◽

2021 ◽

Author(s):

Benjamin K. Young ◽

Mark W. Johnson ◽

Thomas J. Wubben

Keyword(s):

Diabetic Retinopathy ◽

Cost Analysis ◽

Vitreous Hemorrhage ◽

Intravitreal Aflibercept

Repeated intravitreal bevacizumab (Avastin®) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation

Acta Ophthalmologica ◽

10.1111/j.1755-3768.2009.01622.x ◽

2009 ◽

Vol 89 (1) ◽

pp. 76-81 ◽

Cited By ~ 26

Author(s):

Gerald Schmidinger ◽

Noemi Maar ◽

Matthias Bolz ◽

Christoph Scholda ◽

Ursula Schmidt-Erfurth

Keyword(s):

Diabetic Retinopathy ◽

Intravitreal Bevacizumab ◽

Panretinal Photocoagulation

Clinical efficacy and acceptability of panretinal photocoagulation combined with conbercept for patients with proliferative diabetic retinopathy

Medicine ◽

10.1097/md.0000000000025611 ◽

2021 ◽

Vol 100 (17) ◽

pp. e25611

Author(s):

Liangyu Wang ◽

Zhaoli Chen ◽

Xiaoxue Wang

Keyword(s):

Diabetic Retinopathy ◽

Clinical Efficacy ◽

Panretinal Photocoagulation